SCP
BMY icon

Shorepoint Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History

Shorepoint Capital Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$3.05M Buy
+67,705
New +$3.16M 0.61% 60
2025
Q1 		$3.78M Buy
61,924
+3,498
+6% +$204K 0.85% 51
2024
Q4 		$3.3M Buy
58,426
+1,248
+2% +$69.7K 0.76% 53
2024
Q3 		$2.96M Sell
57,178
-28,497
-33% -$1.34M 0.67% 63
2024
Q2 		$3.56M Sell
85,675
-8,753
-9% -$392K 0.84% 48
2024
Q1 		$5.12M Buy
94,428
+2,788
+3% +$142K 1.25% 30
2023
Q4 		$4.7M Buy
91,640
+5,849
+7% +$307K 1.26% 32
2023
Q3 		$4.98M Buy
85,791
+4,075
+5% +$250K 1.46% 22
2023
Q2 		$5.23M Buy
81,716
+829
+1% +$55.6K 1.47% 24
2023
Q1 		$5.61M Sell
80,887
-3,705
-4% -$261K 1.6% 20
2022
Q4 		$6.09M Buy
84,592
+1,076
+1% +$81.1K 1.69% 17
2022
Q3 		$5.94M Buy
83,516
+1,453
+2% +$105K 2.83% 6
2022
Q2 		$6.32M Sell
82,063
-4,273
-5% -$325K 2.67% 6
2022
Q1 		$6.3M Sell
86,336
-931
-1% -$62.5K 2.63% 8
2021
Q4 		$5.44M Buy
87,267
+3,208
+4% +$188K 2.21% 13
2021
Q3 		$4.97M Buy
+84,059
New +$5.54M 2.24% 13
2021
Q1 		$4.49M Buy
71,051
+6,099
+9% +$379K 2.4% 10
2020
Q4 		$4.03M Buy
64,952
+2,504
+4% +$154K 2.23% 12
2020
Q3 		$3.77M Buy
62,448
+7,339
+13% +$442K 2.34% 12
2020
Q2 		$3.24M Buy
55,109
+21,499
+64% +$1.29M 2.11% 12
2020
Q1 		$1.87M Buy
+33,610
New +$2.05M 1.5% 29

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Shorepoint Capital Partners's BMY Position: Q3 2025 in Review

Shorepoint Capital Partners opened a new position in Bristol-Myers Squibb (BMY) in Q3 2025: 67,705 shares worth $3.05M. The stake represents 0.61% of the portfolio and ranks #60 among its holdings. This is a return to the name: Shorepoint Capital Partners previously reported a position in BMY as recently as Q1 2025.

Shorepoint Capital Partners first reported a position in BMY in Q1 2020 and has held it in 21 quarters since. The position peaked at $6.32M in Q2 2022. 2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Shorepoint Capital Partners held 67,705 shares of Bristol-Myers Squibb worth $3.05M as of Q3 2025.
  • Bristol-Myers Squibb was a new Shorepoint Capital Partners position in Q3 2025.
  • Bristol-Myers Squibb made up 0.61% of Shorepoint Capital Partners's portfolio in Q3 2025, its #60 holding.
  • Shorepoint Capital Partners first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 21 quarters since.
  • Shorepoint Capital Partners's Bristol-Myers Squibb position peaked at $6.32M in Q2 2022.
  • 2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Shorepoint Capital Partners's 13F filing for Q3 2025, filed 3 Oct 2025.